Ozempic

Retatrutide beat Ozempic on blood sugar and weight in Lilly's diabetes trial

In an 80-week trial of 1,298 adults with type 2 diabetes, Lilly's experimental weekly shot lowered A1C more than Ozempic 2 mg and roughly doubled the weight loss. It is not approved, and the full data are not published yet.